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Abstract The complex anatomy of the mammalian pancreas, in 
which the endocrine cells are grouped in islets dispersed among 
the predominant exocrine component, has hampered study of the 
molecular events governing the development of pancreatic cell 
lineages. To investigate whether fish may provide relevant, 
complementary models of pancreas development, we character-
ized the trout insulin (tINS) promoter and its molecular 
interactions with PDX1, a key transcriptional and developmental 
factor of the mammalian pancreas. Transfection of a luciferase 
reporter plasmid containing the 280 bp 5'-flanking region of the 
tINS gene resulted in strong activity in mammalian pancreatic ß 
cells but not in CHO or pituitary cells. Footprinting assays and 
cotransfection experiments indicated that mammalian PDX1 
binds to and activates the tINS promoter. By microinjecting 
plasmids to fertilized zebrafish eggs, we showed that the 
expression of mouse PDX1 is capable of activating the co-
injected tINS promoter plasmid in most cell types of the 24-h 
zebrafish embryo. The conserved role of PDX1 in vertebrate 
insulin gene regulation opens the possibility to exploit fish models 
in the study of pancreas development. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
The mammalian pancreas develops as an outpocketing of 
the primitive embryonic foregut to eventually produce a het-
erogeneous organ containing an exocrine and an endocrine 
component [1]. The endocrine cells are arranged in clusters 
or 'islets' of cells containing four distinct cell types: a (A), 
ß (B), 5 (D), and PP, which are responsible for production of 
the specific hormones glucagon, insulin, somatostatin and 
pancreatic polypeptide, respectively [2]. In part because of 
its complexity, relatively little information is available con-
cerning the molecular events underlying formation and devel-
opment of the mammalian pancreas. 
The ß cell-specific expression of mammal ian insulin genes is 
controlled at the transcriptional level, through several well 
defined eis elements located in the proximal 5'-flanking region 
[3-6]. Several of the transcription factors involved in cell-spe-
cific transcription have been defined: they include PDX1 (also 
called STF1, IPF1 or IDX1) [7-9], a variant homeodomain 
protein which recognizes A/T-rich sites in the D N A , and sev-
eral basic helix-loop-helix (bHLH) proteins including BETA2 
(NeuroD) [10,11] and E2A [12-14]. Although neither P D X 1 
nor BETA2 is exclusively expressed in ß cells (PDX1 is also 
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found in intestinal epithelial cells [7] and BETA2 in brain cells 
[10]), P D X 1 , BETA2 and E2A interact synergistically on the 
insulin promoter to ensure a high level of ß cell-specific tran-
scription [10,15]. 
Implicit in the search for pancreatic gene transcription fac-
tors has been the expectation that such proteins would them-
selves be involved in early development of pancreatic cell lin-
eages or would aid in isolating genes controlling early 
pancreatic development. Indeed, targeted inactivation of the 
PDX1 gene in mice leads to failure of pancreas development 
[16], clearly showing that, in addition to its role as an insulin 
gene transcription factor, PDX1 plays an essential role in 
early pancreatic development. 
Teleost fish species display striking diversity in the relation-
ship of endocrine to exocrine pancreas cells, ranging from 
species where the two cell types are intermingled, as in the 
other vertebrates, to species where they are anatomically sep-
arated. In the latter species, such as rainbow trout (Oncorhyn-
chus mykiss), the endocrine cells are located in Brockmann 
bodies, comprising mostly endocrine tissue [17]. The separa-
tion of endocrine and exocrine populations in certain fish 
species offers the prospect of simpler analysis of pancreatic 
cell development. Towards this end, we have begun a study 
of the transcriptional control mechanisms underlying expres-
sion of the trout insulin (tINS) gene. As a first step, we have 
isolated and characterized the promoter of the gene. Although 
the proximal 5'-flanking region shows no striking sequence 
similarities to that of mammalian insulin genes, it functions 
in ß cell-specific fashion upon transfection to mammalian 
cells. Based on a combination of in vitro and in vivo analyses, 
we showed that this preferential activity was due, at least in 
part , to the action of P D X 1 . We also showed that PDX1 is 
capable of activating the t INS promoter in a wide range of 
cell types of the developing zebrafish. 
2. Materials and methods 
2.1. Plasmids and mutagenesis 
The pO-Luc reporter plasmid encoding the firefly luciferase gene [18] 
is described elsewhere [19]. The pCMV-ßgal plasmid [20] encodes the 
E. coll ß-galactosidase reporter gene under the control of the cytome-
galovirus (CMV) promoter/enhancer region. pCMV-mPDXl was pre-
pared by cloning the mouse PDX1 (mPDXl) coding sequence [8] into 
the pcDNA-3 expression vector (Invitrogen). The 5'-flanking region 
(-280/+4) of the tINS promoter (280INS) was amplified from trout 
genomic DNA by PCR, directly sequenced and cloned in pGEM [21] 
yielding the pIN vector. The Sa/I/BamHI fragment of 280INS from 
pIN was cloned into the same sites of pO-Luc yielding the p280INS-
Luc reporter plasmid. Two truncated derivatives (pl60INS-Luc and 
pl05INS-Luc) containing the -160/+4 and -105/+4 regions of the 
tINS gene, respectively, were prepared by PCR amplification from 
p280INS-Luc and cloning the resulting fragments in pO-Luc. The 
plasmid p468GH-Luc, containing the —468/+24 region of the trout 
growth hormone (GH) gene, has been described elsewhere [19]. 
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2.2. Cell culture and transfections 
GC (rat pituitary tumor cells), HIT T15 M2.2.2 (hamster pancreatic 
ß cells) and CHO (Chinese hamster ovary cells) were grown and trans-
fected as described previously [19,22]. Briefly, the cells were cultured 
in Ham's F12 medium (GC and CHO) or DMEM (HIT), supple-
mented with 10% fetal calf serum and penicillin/streptomycin. Trans-
fections were performed by electroporation (GC: 300 V, 1500 uF) or 
calcium phosphate precipitation (CHO and HIT) using the indicated 
amounts of plasmid and cells. Each transfection included 2 u,g of 
pCMV-ßgal to normalize the data to transfection efficiency. 48 h after 
transfection, the cells were washed and collected in PBS, and resus-
pended in 200 ul of 20 mM Tricine (pH 7.8), 2 mM EDTA, 1 mM 
dithiothreitol, 1% Triton X-100 and 15% glycerol. The suspension was 
centrifuged for 1 min and the supernatant solution was processed for 
assay of luciferase and ß-galactosidase activities as described [19]. 
2.3. DNase I footprinting 
Nuclear extracts were prepared from HIT cells as described [23]. 
For the preparation of recombinant mPDXl, a 1060 bp fragment of 
the mouse PDX1 gene [8] encoding amino acids 6-284 was subcloned 
to the vector pRSET-B (Invitrogen) and introduced into E. coli 
JM109 cells. Bacteria were incubated in the presence of 1 mM iso-
propyl-ß-D-thiogalactopyranoside and the His-tagged PDX1 protein 
purified with nickel-chelating resin according to the manufacturer's 
instructions (Invitrogen). DNA fragments were end-labelled (8 ng, 
2X104 cpm) and incubated with the indicated amounts of HIT nu-
clear extracts or purified mPDXl protein, and then partially digested 
with DNase I according to Galas and Schmitz [24]. 
2.4. Microinjection 
Zebrafish were raised and bred according to standard methods [25]. 
Microinjection was performed as described previously [22]. Briefly, 
fertilized zebrafish eggs were collected, placed in 1.2% agarose gel 
grooves, injected using glass capillaries containing the appropriate 
DNA at 40 ug/ml and incubated at 28.5°C for 24 h. In situ assay 
to reveal ß-galactosidase-positive cells was performed as described 
[22,26]. Embryos were examined using Nomarski optics and blue cells 
were classified into five major groups (skin, sclerotome, myotome, 
notochord and nervous system), according to the criteria of cell loca-
tion and morphology adopted by Westerfield et al. [26]. 
3. Results 
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Fig. 1. A: Sequence of the 5'-flanking region (-280/+4) of the tINS 
promoter. The three regions protected from DNase I digestion by 
recombinant mouse PDX1 (see Fig. 3) are in capital letters. Within 
each footprint, the CTAATG sequence and its closely related motifs 
are in bold characters. The TATA box is underlined and the tran-
scription start site is indicated by an arrowhead. The 5' end of the 
two deletion mutants used in this investigation (—160 and —105) 
are indicated. B: Comparison of the three potential PDX1 binding 
sites in the tINS promoter with characterized PDX1 binding sites in 
mammalian genes. The Al [6] and TSEI [7] PDX1 binding sites are 
from the insulin (human, mouse, rat I and II, guinea pig) and so-
matostatin (rat) promoters, respectively. Lower case letters indicate 
deviation from the consensus sequence. The sequence at —116/—121 
is located on the lower strand. 
3.1. The trout insulin promoter shows preferential activity in 
hamster pancreatic ß cells 
The promoters of the trout GH and prolactin genes confer 
pituitary-specific expression to a reporter gene in mammalian 
cells [19,27]. As a first step to study the regulation of the tINS 
gene, we therefore investigated whether its promoter could 
likewise drive the expression of a reporter gene in a cell-spe-
cific manner in mammalian cells. The sequence of the tINS 
promoter amplified from trout genomic DNA is shown in Fig. 
1A. Computer comparisons with mammalian insulin pro-
moters failed to reveal extensive regions of homology. The 
transcriptional activity of p280INS-Luc, a plasmid bearing 
the 5'-flanking region (-280/+4) of the tINS gene fused to 
the luciferase reporter gene, was tested in various mammalian 
cell lines. As shown in Fig. 2, p280INS-Luc could efficiently 
drive luciferase activity in hamster pancreatic ß cells (HIT), 
which produce insulin, but not in hamster CHO cells or rat 
pituitary GC cells, neither of which expresses this hormone. 
Conversely, the p468GH-Luc plasmid, containing the pro-
moter of the trout GH gene linked to the luciferase gene, 
was effectively activated (because of endogenous expression 
of the transcription factor Pit-1) in GH-producing GC cells, 
as shown previously [19], but not in HIT or CHO cells, which 
express neither Pit-1 nor GH (Fig. 2). Thus, the -280/+4 
region of the tINS gene confers ß cell-specific expression to 
a reporter gene in mammalian cells. 
3.2. Mammalian PDX1 binds to the promoter of the trout 
insulin gene 
Since the above experiment implied an interaction of HIT 
cell nuclear proteins with the tINS promoter, we performed a 
DNase I protection assay to identify the relevant binding sites. 
Two adjacent A/T-rich sequences of the tINS promoter that 
contain CTAATG or closely related motifs (Fig. IB) were 
protected from DNase I digestion by nuclear extracts of 
HIT cells (Fig. 3, lanes 1-3; see also Fig. 1). In mammals, 
the CTAATG motif occurs in the binding sites for PDX1, a 
pancreas-specific transcription factor involved in the activa-
tion of the insulin and somatostatin promoters [6,7] (Fig. 
IB). Thus, the fact that PDX1 is expressed in HIT cells sug-
gested that the footprints produced by HIT cell extracts could 
have been generated by this protein. This idea was confirmed 
by a footprinting assay performed with bacterially expressed 
mPDXl. In fact, recombinant mPDXl produced three adja-
cent footprints extending over the same region of the pro-
moter protected by the HIT extracts (Fig. 3, lanes 5-7). Pro-
tection of the two proximal sites required a higher 
concentration of mPDXl than that required to protect the 
distal site. This suggests that this latter site, which bears a 
CTAATG motif, has a higher affinity for mPDXl than the 
two proximal ones, which contain a CTAACG and a 
CAAATG sequence, respectively. 
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Fig. 2. The UNS promoter is specifically activated in pancreatic ß 
cells. Hamster CHO (5X105), rat pituitary GC (2X106) and ham-
ster ß-pancreatic HIT (106) cells were transfected with 7 |xg of the 
indicated plasmids. Data, expressed as fold activation relative to the 
promoterless (pO-Luc) plasmid, are the mean ± S.E.M. of at least 
three independent transfections. 
3.3. Mouse PDXl activates the trout insulin promoter 
To determine whether the activation of the tINS promoter 
in HIT cells could be accounted for by the action of PDXl, 
we performed a cotransfection experiment in CHO cells using 
a cytomegalovirus enhancer-driven expression plasmid 
(pCMV-mPDXl) encoding mPDXl. Cotransfection of CHO 
cells with p280INS-Luc in the presence of increasing amounts 
of pCMV-mPDXl led to a dose-dependent and saturable in-
crease of luciferase activity (Fig. 4A), showing that mPDXl 
can activate the tINS promoter in non-pancreatic mammalian 
cells. On the other hand, in HIT cells, the activity of pl60INS-
Luc, which lacks the distal high affinity PDXl site, was re-
duced to 10% of that of p280INS-Luc, while pl05INS-Luc, 
which lacks the whole PDXl binding region, showed only 
minimal luciferase activity (Fig. 4B). These results indicate 
that the PDXl binding sequences, in particular the distal 
PDXl binding site, are required for optimal activation of 
the tINS promoter in HIT cells. 
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tINS promoter, the expression of the reporter gene was also 
detected in virtually all the major tissues (Fig. 5). Conversely, 
stained cells were not observed in embryos coinjected with 
pcDNA-3 and p280INS-ßgal (not shown), consistent with 
the fact that pancreatic exocrine and endocrine cells do not 
appear until around day 3 of development [28] and indicating 
that activation of the tINS promoter was due to mPDXl 
produced by the expression vector. Hence, we conclude that 
mPDXl is sufficient to transactivate the tINS promoter in all 
the main tissues of 24-h zebrafish embryos. 
4. Discussion 
In the present investigation we show that the role of PDXl 
in regulating the transcription of the insulin gene is conserved 
in vertebrates. This opens the possibility of exploiting the 
peculiarity of fish pancreas anatomy in the study of the mo-
lecular events driving its organogenesis. From an evolutionary 
viewpoint, insulin-expressing cells appear to have progressed 
from endocrine cells of the open type scattered in the gut, as 
observed in protochordates (tunicates and Amphioxus) to en-
docrine cells of the closed type either clustered in a paraintes-
tinal islet organ, as in cyclostomes, or finally grouped into 
islets within the exocrine pancreas, as in gnathostomes. The 
trend towards cellular aggregation away from the gut is max-
3.4. Mouse PDXl activates transcription of the trout insulin 
promoter in all the main tissues of 24-h zebrafish embryos 
To investigate whether PDXl is able to transactivate the 
tINS promoter in fish cells, we used the zebrafish transient 
expression system [26]. In this model, reporter plasmids are 
microinjected into fertilized zebrafish eggs and the distribution 
of reporter gene expression in the different tissues of 24-h 
embryos is revealed histochemically. Microinjection of 1-2 
cell zebrafish embryos with pCMV-ßgal, a reporter plasmid 
bearing the ß-galactosidase reporter gene under the control of 
the CMV enhancer, resulted in a mosaic expression of the 
reporter in all the main tissues of 24-h embryos (Fig. 5). 
This result, which is in accord with previous findings [22,26], 
is due to the random distribution of injected DNA within the 
embryo and to the capacity of the CMV enhancer to activate 
transcription ubiquitously. In embryos coinjected with 
pCMV-mPDXl and p280INS-ßgal, a reporter plasmid con-
taining the ß-galactosidase gene under the control of the 
Fig. 3. DNase I footprinting analysis performed with nuclear ex-
tracts of HIT cells (left) or recombinant mouse PDXl protein 
(right). The labelled tINS promoter was incubated with: 0 (lane 1), 
80 (lane 2) or 200 (lane 3) jig of HIT nuclear extracts, or with: 0 
(lane 5) 200 (lane 6) or 400 (lane 7) ng of recombinant mouse 
PDXl. Lanes 4 and 8: Maxam-Gilbert G+A sequencing ladder. 
DNase I digestions were performed with the following concentra-
tions (ng/ml) of enzyme: 1.2 (lanes 1, 5, 6 and 7), 3.6 (lane 2) and 
12 (lane 3). 
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Fig. 4. A: Mouse PDXl activates the tINS promoter. CHO cells (5X105) were cotransfected with p280INS-Luc (5 ug) and increasing amounts 
(0, 0.06, 0.12, 0.25, 0.5 and 2 |ig) of pCMV-mPDXl (encoding mouse PDXl); the total amount of transfected DNA was kept constant by ad-
dition of empty pCMV vector. Values from two independent transfections are shown. B: Deletion analysis of the tINS promoter in ß cells. 
HIT ß cells (106) were transfected with 7 |xg of the indicated reporter plasmids. Data are the mean ± S.E.M. of three independent transfections. 
The presence and position of the three footprints obtained with recombinant mouse PDXl (see Figs. 1 and 3) are schematically depicted on 
the left. 
imally expressed in several higher teleosts in which islet cells 
are concentrated exclusively into one or a few Brockmann 
bodies composed mainly of ß cells and receiving only minor 
contributions from the exocrine pancreas [17]. Thus, tissue 
heterogeneity is minimized in higher teleosts, a fact which 
may reflect more straightforward mechanisms for islet forma-
tion. This would make teleosts an attractive experimental 
model for developmental studies on the endocrine pancreas. 
Furthermore, in zebrafish, large-scale genetic screens have 
been initiated which have the potential to lead to identifica-
tion of developmental control genes [29]. On the other hand, 
the diffuse nature of the acinous component in bony fish as 
opposed to the compact organ found in tetrapods would 
make the latter a better alternative to investigate the morpho-
genesis of the exocrine pancreas. 
There has been controversy concerning the embryological 
origin and lineage relationships of the cells comprising the 
mammalian endocrine pancreas. Since pancreatic islet cells 
express a number of proteins characteristic of nervous tissue, 
it has been suggested that these cells originate from the neural 
crest, in contrast to the exocrine cells which are clearly derived 
from the gut endoderm [1,30]. Several studies are inconsistent 
with this neural crest hypothesis and it is currently believed 
that both endocrine and exocrine cells derive from the endo-
derm [30]. However, the lineage relationships among the en-
docrine cells remain unclear. On the basis of co-expression of 
islet hormones early in development, it has been proposed 
that all endocrine cells derive from a pluripotent stem cell: 
progressive differentiation of these cells would lead to a grad-
ual restriction of the phenotype culminating in the mature cell 
which is capable of producing only its characteristic hormone 
[31,32]. On the other hand, extensive co-expression has not 
been observed by other workers [33,34] and, furthermore, re-
sults of cell ablation experiments using diphtheria toxin trans-
genes do not support the common endocrine stem cell idea 
[35]. Interestingly, four zebrafish mutants were recently iden-
tified, which showed almost complete loss of pancreatic exo-
crine cells but little or no effect on islet cells [28]. 
In recent years, much effort has been devoted to under-
standing the molecular mechanisms regulating the cell-specific 
expression of pancreatic genes in mammals. In particular, a 
number of transcription factors which play a key role in di-
recting ß cell-specific transcription of the insulin gene have 
been described. These include the homeodomain protein, 
PDXl [7-9], and the bHLH proteins BETA2 [10,11] and 
E2A [13,14]. Our experiments strongly indicate that PDXl 
plays an equally important role in fish insulin gene expression : 
not only does mouse PDXl bind to regions of the promoter 
F. Argenton et al.lFEBS Letters 407 (1997) 191-196 195 
where in the tINS gene. Further studies on fish insulin gene 
expression and the relevant transcription factors, including 
PDX1, may significantly increase our understanding of pan-
creas development. 
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